002317 众生药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.4296.917-7.2346.5348.973
总资产报酬率 ROA (%)1.9075.162-4.9814.3046.032
投入资产回报率 ROIC (%)2.1645.840-5.5594.7986.656

边际利润分析
销售毛利率 (%)57.28756.11956.03458.59664.857
营业利润率 (%)17.97211.824-11.34611.44313.985
息税前利润/营业总收入 (%)18.69811.548-13.25511.50915.901
净利润/营业总收入 (%)15.70310.572-15.1569.57311.784

收益指标分析
经营活动净收益/利润总额(%)93.476100.137-71.135111.06888.538
价值变动净收益/利润总额(%)-8.251-0.982-1.980-14.7027.290
营业外收支净额/利润总额(%)4.675-0.57816.652-5.314-1.618

偿债能力分析
流动比率 (X)4.1354.2372.8773.9012.918
速动比率 (X)3.7093.7292.5103.3882.484
资产负债率 (%)20.43919.09927.79129.92733.917
带息债务/全部投入资本 (%)6.7453.65414.22610.78117.491
股东权益/带息债务 (%)1,300.6412,476.886554.749696.408409.311
股东权益/负债合计 (%)381.033414.223253.650225.383189.029
利息保障倍数 (X)-120.123-55.285-37.05117.9007.436

营运能力分析
应收账款周转天数 (天)82.00078.91073.95367.71866.894
存货周转天数 (天)121.400131.182159.599166.773178.616